The 'swallow tail' appearance of the healthy nigrosome - A new accurate test of Parkinson's disease: A case-control and retrospective cross-sectional MRI study at 3T

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Schwarz, Stefan T ^a   Afzal, Mohammed ^b   Morgan, Paul S ^b   Bajaj, Nin ^b   Gowland, Penny A ^c   Auer, Dorothee P ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NIGROSOME 1; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATIENT CODING; PROSPECTIVE STUDY; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; SUSCEPTIBILITY WEIGHTED IMAGING; IMAGE PROCESSING; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA;

EID: 84899452110     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093814     Document Type: Article

References (35)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
2. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain J Neurol 125: 861-870. (Pubitemid 34279780)
3. Schrag A, Ben-Shlomo Y, Quinn N (2002) How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry 73: 529-534. (Pubitemid 35246805)
4. Meara J, Bhowmick BK, Hobson P (1999) Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing 28: 99-102. (Pubitemid 29161211)
5. Hauser RA, Grosset DG (2012) [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes. J Neuroimaging Off J Am Soc Neuroimaging 22: 225-230. doi:10.1111/j.1552-6569.2011.00583.x.
6. Bajaj N, Hauser RA, Grachev ID (2013) Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2012-304436.
7. Wang J, Hoekstra JG, Zuo C, Cook TJ, Zhang J (2013) Biomarkers of Parkinson's disease: current status and future perspectives. Drug Discov Today 18: 155-162. doi:10.1016/j.drudis.2012.09.001.
8. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain J Neurol 114 (Pt 5): 2283-2301.
9. Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain J Neurol 122 (Pt 8): 1421-1436. (Pubitemid 29374121)
10. Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain J Neurol 122 (Pt 8): 1437-1448. (Pubitemid 29374122)
11. Blazejewska AI, Schwarz ST, Pitiot A, Stephenson MC, Lowe J, et al. (2013) Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology 81: 534-540. doi:10.1212/WNL. 0b013e31829e6fd2.
12. Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, et al. (2010) Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis 7: 300-318. doi:10.1159/000314495.
13. Hotter A, Esterhammer R, Schocke MFH, Seppi K (2009) Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism. Mov Disord 24: S711-S720. doi:10.1002/mds.22648.
14. Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, et al. (2011) T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Mov Disord Off J Mov Disord Soc 26: 1633-1638. doi:10.1002/mds.23722.
15. Lotfipour AK, Wharton S, Schwarz ST, Gontu V, Schäfer A, et al. (2012) High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging Jmri 35: 48-55. doi:10.1002/jmri.22752.
16. Bak TH, Mioshi E (2007) A cognitive bedside assessment beyond the MMSE: the Addenbrooke's Cognitive Examination. Pract Neurol 7: 245-249. (Pubitemid 47193708)
17. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
18. Fahn S, Jenner P, Marsden CD, Teychenne P (1987) Fahn S, Elton RI, and members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, et al, eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information.
19. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-442.
20. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-1534. (Pubitemid 20351344)
21. Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, et al. (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30: 1323-1341. doi:10.1016/j.mri.2012.05.001.
22. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326: 41-44. (Pubitemid 36110721)
23. Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, et al. (2011) QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies. Ann Intern Med 155: 529-536. doi:10.7326/0003-4819-155-8-201110180- 00009.
24. Kwon D-H, Kim J-M, Oh S-H, Jeong H-J, Park S-Y, et al. (2012) Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol 71: 267-277. doi:10.1002/ana.22592.
25. Schwarz ST, Abaei M, Gontu V, Morgan PS, Bajaj N, et al. (2013) Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin 3: 481-488. doi:10.1016/j.nicl.2013.10.006.
26. Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, et al. (2008) Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. J Neurochem 106: 1866-1875. doi:10.1111/j.1471-4159.2008.05541.x.
27. Wallis LI, Paley MNJ, Graham JM, Gruenewald RA, Wignall EL, et al. (2008) MRI Assessment of Basal Ganglia Iron Deposition in Parkinson's Disease. J Magn Reson Imaging 28: 1061-1067. doi:10.1002/jmri.21563.
28. Zhang W, Sun S-G, Jiang Y-H, Qiao X, Sun X, et al. (2009) Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging. Neurosci Bull 25: 353-360. doi:10.1007/s12264-009-0225- 8.
29. Baudrexel S, Nürnberger L, Rüb U, Seifried C, Klein JC, et al. (2010) Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease. Neuroimage 51: 512-520. doi:10.1016/j.neuro image.2010.03.005.
30. De Lau LM, Breteler MM (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5: 525-535. doi:16/S1474-4422(06)70471-9.
31. Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7: 1044-1055. doi:10.1016/S1474-4422(08)70239-4.
32. Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, et al. (2012) Conventional Magnetic Resonance Imaging in Confirmed Progressive Supranuclear Palsy and Multiple System Atrophy. Mov Disord 27: 1755-1762. doi:10.1002/mds.24968.
33. Meijer FJA, Bloem BR, Mahlknecht P, Seppi K, Goraj B (2013) Update on diffusion MRI in Parkinson's disease and atypical parkinsonism. J Neurol Sci 332: 21-29. doi:10.1016/j.jns.2013.06.032.
34. Lehéricy S, Sharman MA, Dos Santos CL, Paquin R, Gallea C (2012) Magnetic resonance imaging of the substantia nigra in Parkinson's disease. Mov Disord Off J Mov Disord Soc 27: 822-830. doi:10.1002/mds.25015.
35. Kohn MA, Carpenter CR, Newman TB (2013) Understanding the Direction of Bias in Studies of Diagnostic Test Accuracy. Acad Emerg Med Off J Soc Acad Emerg Med 20: 1194-1206. doi:10.1111/acem.12255.